A harmonized single-cell transcriptomic atlas of human neuroblastoma
- Author
- Noah Bonine (UGent) , Vittorio Zanzani (UGent) , Liselot Mus (UGent) , Bavo Vanneste (UGent) , Christian Zwicker (UGent) , Tinne Thoné (UGent) , Sofie Roelandt (UGent) , Cécile Thirant, Amira Kramdi, Isabelle Janoueix-Lerosey, Bram De Wilde (UGent) , Celine Everaert (UGent) , Vanessa Vermeirssen (UGent) , Charlotte Scott (UGent) , Franki Speleman (UGent) and Katleen De Preter (UGent)
- Organization
- Abstract
- Background: Single-cell and single-nucleus RNA sequencing (scRNA-seq or snRNA-seq) are powerful technologies to study the transcriptomic heterogeneity of tumors, including neuroblastoma. Previous studies using scRNA-seq and snRNA-seq were focused on tumoral heterogeneity and aggressiveness in relation to normal developmental and cell-of-origin. While useful, these studies have also raised novel questions. Aims: At present, a comprehensive overview of these studies and data is lacking. In this study, we present a meta-analysis of published scRNA-seq and snRNA-seq datasets for neuroblastoma patient tumors. We compared wet lab and bioinformatics processing procedures across these studies and combined data to form an integrated transcriptomic atlas of human neuroblastoma tumors. Methods: We reviewed all published scRNA-seq and snRNA-seq (n=9) studies and collected metadata, including patient information, sample processing details, wet lab protocol, and bioinformatics approaches (quality control, canonical gene marker selection, and cell type annotation). Thereafter, selected studies were combined to generate a cellular atlas, using benchmarked integration tools to correct for technical bias while preserving biological heterogeneity. Results: Different wet lab protocols and bioinformatics pipelines were applied across the different studies. Most notably, this resulted in a discrepancy in the tumoral composition obtained with scRNA-seq compared to snRNA-seq, with a lack of neuroendocrine cells in scRNA-seq data. Data from more than 50 tumors across various studies (performed on the 10X Genomics platform) were normalized to largely overcome differences in the applied wet lab and bioinformatics approaches. As a result, a harmonized atlas of the transcriptomic landscape of human neuroblastoma tumors was generated. This atlas allows for gaining a more comprehensive view of the heterogeneity of malignant cells and the tumor microenvironment. To illustrate the power of the generated cell atlas as a framework for future single-cell studies, we mapped newly generated scRNA-seq and snRNA-seq data to this reference atlas for cell annotation and observed agreement with manual cell annotation. Conclusion: Our study provides a comprehensive and harmonized view of the single-cell transcriptomic landscape of neuroblastoma and serves as a valuable reference resource for newly generated scRNA-seq and snRNA-seq data.
Downloads
-
Abstract-Abstract Book Bonine Noah-ANR2023.pdf
- full text (Published version)
- |
- open access
- |
- |
- 223.56 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HXVKHADJ9ZR49TTB9V1SFQQW
- MLA
- Bonine, Noah, et al. “A Harmonized Single-Cell Transcriptomic Atlas of Human Neuroblastoma.” Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts, 2023.
- APA
- Bonine, N., Zanzani, V., Mus, L., Vanneste, B., Zwicker, C., Thoné, T., … De Preter, K. (2023). A harmonized single-cell transcriptomic atlas of human neuroblastoma. Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts. Presented at the Advances in Neuroblastoma Research (ANR) Meeting 2023, Amsterdam, the Netherlands.
- Chicago author-date
- Bonine, Noah, Vittorio Zanzani, Liselot Mus, Bavo Vanneste, Christian Zwicker, Tinne Thoné, Sofie Roelandt, et al. 2023. “A Harmonized Single-Cell Transcriptomic Atlas of Human Neuroblastoma.” In Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts. Amsterdam.
- Chicago author-date (all authors)
- Bonine, Noah, Vittorio Zanzani, Liselot Mus, Bavo Vanneste, Christian Zwicker, Tinne Thoné, Sofie Roelandt, Cécile Thirant, Amira Kramdi, Isabelle Janoueix-Lerosey, Bram De Wilde, Celine Everaert, Vanessa Vermeirssen, Charlotte Scott, Franki Speleman, and Katleen De Preter. 2023. “A Harmonized Single-Cell Transcriptomic Atlas of Human Neuroblastoma.” In Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts. Amsterdam.
- Vancouver
- 1.Bonine N, Zanzani V, Mus L, Vanneste B, Zwicker C, Thoné T, et al. A harmonized single-cell transcriptomic atlas of human neuroblastoma. In: Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts. Amsterdam; 2023.
- IEEE
- [1]N. Bonine et al., “A harmonized single-cell transcriptomic atlas of human neuroblastoma,” in Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts, Amsterdam, the Netherlands, 2023.
@inproceedings{01HXVKHADJ9ZR49TTB9V1SFQQW, abstract = {{Background: Single-cell and single-nucleus RNA sequencing (scRNA-seq or snRNA-seq) are powerful technologies to study the transcriptomic heterogeneity of tumors, including neuroblastoma. Previous studies using scRNA-seq and snRNA-seq were focused on tumoral heterogeneity and aggressiveness in relation to normal developmental and cell-of-origin. While useful, these studies have also raised novel questions. Aims: At present, a comprehensive overview of these studies and data is lacking. In this study, we present a meta-analysis of published scRNA-seq and snRNA-seq datasets for neuroblastoma patient tumors. We compared wet lab and bioinformatics processing procedures across these studies and combined data to form an integrated transcriptomic atlas of human neuroblastoma tumors. Methods: We reviewed all published scRNA-seq and snRNA-seq (n=9) studies and collected metadata, including patient information, sample processing details, wet lab protocol, and bioinformatics approaches (quality control, canonical gene marker selection, and cell type annotation). Thereafter, selected studies were combined to generate a cellular atlas, using benchmarked integration tools to correct for technical bias while preserving biological heterogeneity. Results: Different wet lab protocols and bioinformatics pipelines were applied across the different studies. Most notably, this resulted in a discrepancy in the tumoral composition obtained with scRNA-seq compared to snRNA-seq, with a lack of neuroendocrine cells in scRNA-seq data. Data from more than 50 tumors across various studies (performed on the 10X Genomics platform) were normalized to largely overcome differences in the applied wet lab and bioinformatics approaches. As a result, a harmonized atlas of the transcriptomic landscape of human neuroblastoma tumors was generated. This atlas allows for gaining a more comprehensive view of the heterogeneity of malignant cells and the tumor microenvironment. To illustrate the power of the generated cell atlas as a framework for future single-cell studies, we mapped newly generated scRNA-seq and snRNA-seq data to this reference atlas for cell annotation and observed agreement with manual cell annotation. Conclusion: Our study provides a comprehensive and harmonized view of the single-cell transcriptomic landscape of neuroblastoma and serves as a valuable reference resource for newly generated scRNA-seq and snRNA-seq data.}}, articleno = {{O9.3}}, author = {{Bonine, Noah and Zanzani, Vittorio and Mus, Liselot and Vanneste, Bavo and Zwicker, Christian and Thoné, Tinne and Roelandt, Sofie and Thirant, Cécile and Kramdi, Amira and Janoueix-Lerosey, Isabelle and De Wilde, Bram and Everaert, Celine and Vermeirssen, Vanessa and Scott, Charlotte and Speleman, Franki and De Preter, Katleen}}, booktitle = {{Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts}}, language = {{eng}}, location = {{Amsterdam, the Netherlands}}, title = {{A harmonized single-cell transcriptomic atlas of human neuroblastoma}}, url = {{https://www.anr2023.org/resources/uploads/sites/26/2023/05/Abstract-book-oral-presentations_parallel-sessions-ANR2023.pdf}}, year = {{2023}}, }